Oculis Holding AG (OCS) Total Non-Current Liabilities (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Total Non-Current Liabilities of $4.4 million in Q1 2026, up 12.97% quarter-over-quarter from $3.9 million in Q4 2025, and up 91.01% on a YoY basis from $2.3 million in Q1 2025.

Oculis Holding AG (OCS) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Oculis Holding AG's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $4.4 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 91.01% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $4.4 million (up 91.01% YoY), while the FY2025 annual figure was $3.9 million, up 26.08% from the prior year.
  • Total Non-Current Liabilities was $4.4 million for Q1 2026 at Oculis Holding AG, up from $3.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $127.7 million in Q4 2022 to a low of $938676.2 in Q2 2023.
  • Historically, Total Non-Current Liabilities has averaged $12.3 million across 5 years, with a median of $2.5 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities tumbled 98.64% in 2023, then surged 167.65% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $127.7 million in 2022, then sank by 98.64% to $1.7 million in 2023, then surged by 80.18% to $3.1 million in 2024, then increased by 26.08% to $3.9 million in 2025, then increased by 12.97% to $4.4 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $4.4 million (Q1 2026), $3.9 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 42,980.09
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 11.03 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 5.87 Bn
9 Abivax 90.15 Bn 90.15 Bn - 64.76 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 4.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.45 Mn
Dec 31, 2025 3.94 Mn
Sep 30, 2025 4.39 Mn
Jun 30, 2025 2.39 Mn
Mar 31, 2025 2.33 Mn
Dec 31, 2024 3.12 Mn
Sep 30, 2024 3.07 Mn
Jun 30, 2024 2.51 Mn
Mar 31, 2024 1.75 Mn
Dec 31, 2023 1.73 Mn
Sep 30, 2023 1.34 Mn
Jun 30, 2023 938,676.16
Dec 31, 2022 127.71 Mn
Dec 31, 2021 124.65 Mn